Navigation Links
Curemark Closes Series A Financing
Date:8/10/2009

RYE, N.Y., Aug. 10 /PRNewswire/ -- Curemark, a privately held drug research and development company, announced today that it has closed a $6.5M Series A round of funding. Curemark has an open IND for its novel technology for CM-AT for autism. Phase III clinical trials are about to begin at 11 sites across the country.

"The Series A funding will allow us to complete our clinical trials for autism as well as submit multiple IND's for our other pipeline indications," states Dr. Elisa Zinberg Curemark's Vice president of Operations. "Our ability to complete this round of funding through private sources is an outstanding achievement in this economic environment," further states Dr. Zinberg.

With 1 in 150 children diagnosed with autism and costs of $90 billion per year, Curemark has focused its initial product in its pipeline on this condition, which represents the greatest increase in disability in children in the United States.

About CUREMARK LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases especially those with dysautonomic components by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in t
'/>"/>

SOURCE Curemark LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Curemark Appoints Preeminent Pediatrics Gastroenterologist
2. Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
5. BioVascular Inc. Closes $10.87 Million Series C Financing
6. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
7. CoAxia, Inc. Announces $21.5M Series D Financing
8. MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
9. SynergEyes, Inc. Raises $13.3 Million in Series C Financing
10. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
11. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ATLANTA , July 6, 2015 Celtaxsys, ... anti-inflammatory therapeutics, including those with rare and orphan inflammatory ... from the U.S. Food and Drug Administration (FDA) to ... drug candidate, acebilustat (CTX-4430), in adult CF patients in ... in Europe will be filed ...
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
(Date:7/5/2015)... , July 6, 2015 Nihon ... international symposium on Medical-Engineering Collaboration "Medicine Definitely ... July 10, 2015 in Tokyo, Japan ... its medical applied research will present their achievements ... and a new industry produced with 8K technology. ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ... worldwide, today announced that it will report its financial results ... U.S. market closes on May 9, 2011. Mindray,s management will ... 10, 2011 U.S. Eastern Time (8:00 PM on May 10, ...
... Corporation (OTCBB: PRTT) today announced its Board of Directors ... its Chief Executive Officer and Chairman of the Board, ... Operating Officer and Board Member in March 2011, following ... was the Founder and CEO. Mr. Sesha ...
Cached Medicine Technology:Mindray to Report First Quarter 2011 Financial Results on May 9, 2011 2Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer 2
(Date:7/6/2015)... ... July 06, 2015 , ... ... that Randstad Technologies selected Aspect Software Unified IP contact center solution hosted by ... selected Aspect Unified IP as its future call center platform. , Promero ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Diabetes affects many ... More than 29 million Americans have diabetes, the majority of which are Type 2. ... adults or more than one in three, have prediabetes (abnormally high blood sugar levels). ...
(Date:7/6/2015)... Harlingen, Texas (PRWEB) , ... July 06, 2015 , ... ... a thought-provoking look into the economic transformation associated with the U.S. economy over the ... macroeconomic consequences associated with its use. In many ways, the book is a time ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... City Sports, ... City Sports will co-produce two training clinics for first-time triathletes this summer with ethos, ... will take place on Thursday, July 9, at 6:00 p.m. at the North End ...
(Date:7/5/2015)... (PRWEB) , ... July 05, 2015 , ... ... patented products, announces the Weed Master, a landscaping invention that effectively removes ... $75 billion US dollars," says Scott Cooper, CEO and Creative Director of World ...
Breaking Medicine News(10 mins):Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5
... clues to the impact of severe physical, psychosocial suffering, ... Among Jewish survivors of World War II, those who ... risk of cancer, likely due to physical and mental ... Haifa researchers compared cancer rates in more than 300,000 ...
... women, wide waists in men spell trouble, study finds , ... body fat appears to affect the risk of dangerous blood ... women, a new Danish study indicates. , The 10-year study ... of venous thromboembolism (VTE) in women but not men, while ...
... habits can stave off the inevitable declines, research finds , ... that accompany growing old typically speed up after the age ... can slow the inevitable by staying lean, exercising and refraining ... issue of the Archives of Internal Medicine , are ...
... say , MONDAY, Oct. 26 (HealthDay News) -- There,s ... the family safe on Halloween. Some simple precautions will ... , The American Academy of Pediatrics offers the following ... and reflective and short enough to prevent tripping, entanglement ...
... shows they have doubled risk of GERD, may be linked ... World Trade Center rescue workers can add another illness to ... exposure to Ground Zero toxins and the ensuing mental anguish ... A new study shows that 41 percent of World Trade ...
... Oct. 26 Uno Chicago Grill®, America,s Healthiest Chain Restaurant(1), ... fall menu. , This exciting fall menu stars ... are a well-known and popular accent to many dishes, UNO ... the territory of a select few health food aficionados. ...
Cached Medicine News:Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Where You Put on Pounds May Influence Clot Risk 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:Treat Kids to a Safe Halloween 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 2Health News:Go, Go, Goji! UNO(R) Fall Menu Is 'Berry' Delicious 3
... the Finntip Wide is designed especially for ... genomic DNA. This tip eliminates the mechanical ... excellent for use with extremely viscous liquids. ... of the orifice is 1.1 mm or ...
... Finntips have been designed to optimize ... quality of our tip products is widely ... Finntip range has been extended over the ... of standard and special tips including filter ...
... Premium Low Binding, Graduated, Long Reach Pipet Tips ... and 10 L. Reduces DNA and protein binding. ... of Ultra-Micro Pipettors up to 10 L. Produced ... free. AVR9LS is the Sterile Racked packaged 96 ...
... disposable pipette tips, TowerPacks are ... Each Sterilized TowerPack is individually ... to help protect tips from ... the red sticker, which indicates ...
Medicine Products: